Where does Glycomimetics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Glycomimetics, Inc. ranks #14,010 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Glycomimetics, Inc. hold?

Glycomimetics, Inc. holds 21 US utility patents granted between 2015 and 2024, spanning 7 technology areas.

What is Glycomimetics, Inc.'s Innovation Score?

Glycomimetics, Inc. has an Innovation Score of 47.3 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Glycomimetics, Inc. focus on?

Glycomimetics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 20 patents, ranking #980 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Glycomimetics, Inc.'s patent grant rate increasing or decreasing?

Glycomimetics, Inc.'s recent grant velocity is +220% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Glycomimetics, Inc.'s patents?

Glycomimetics, Inc.'s patents average 32.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Glycomimetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Glycomimetics, Inc.

USPTO PatentsView assignee record - 21 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glycomimetics ranks #14,010 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 7 technology areas.

#14,010
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.3/100): 32.6
avg claims per patent: +220%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14010 · US Corporation #14,010 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #14,010/49,997
PHOTO-FINISH Geze
CPC-NARROW A61P · 7 areas
INNOV-PAR 47.3/100
CLAIMS-DENSE 32.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +220% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Geze GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glycomimetics’s 47.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (23%) Velocity 12.2 pts (26%) Breadth 9.4 pts (20%) Claim depth 15.0 pts (32%)

Qualcomm Incorporated · highest

85
Guehring KG · near

47
Dominion Energy · near

47
Glycomimetics · this assignee

47
Invidi · near

47
SK Planet · near

47
3D Lighting… · lowest

7

What this shows Glycomimetics's Innovation Score is 47.3/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glycomimetics?

Each dot is one of Glycomimetics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glycomimetics’s own 32.6 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Glycomimetics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glycomimetics's grants concentrate

Glycomimetics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 95.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2015. By volume, Glycomimetics sits between Geze GMBH and Gravitron, LLC.

Glycomimetics's three-year grant acceleration

Glycomimetics, Inc. shows 11 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Geze

21
Giesecke+Devrient…

21
Giftedness AND Cr…

21
Globegou WZ

21
Glykos Finland OY

21
GM Global Operati…

21
Grant Prideco

21
Gravitron

21
Glycomimetics ◀

21

What this shows Glycomimetics holds 21 patents at rank #14,003, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Glycomimetics

By rank, the assignees closest to #14,003 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Glycomimetics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Glycomimetics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Glycomimetics ranks #980 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Dominion Energy, Inc. 47 Invidi Technologies Corporation 47 SK Planet Co., Ltd. 47 Guehring KG 47

Glycomimetics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Glycomimetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.8%
2017	2	9.5%
2018	1	4.8%
2019	1	4.8%
2020	2	9.5%
2021	3	14.3%
2022	3	14.3%
2023	5	23.8%
2024	3	14.3%

Which technologies does Glycomimetics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 18

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 15

C09C - Treatment OF Inorganic Materials, Other Than Fibrous Fillers, TO Enhance Their Pigmenting OR Filling Properties ; Preparation OF Carbon Black ; ; Preparation OF Inorganic Materials Which ARE NO Single Chemical Compounds AND Which ARE Mainly Used AS Pigments OR Fillers 6

C07D - Heterocyclic Compounds 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07K - Peptides 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Glycomimetics, Inc.'s patent record in context - here's where to go next.

Glycomimetics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #14,010 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Glycomimetics, Inc. against Geze GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.